Abstract
Drug-induced autoimmune disease was initially described decades ago, with reports of vasculitis and a lupus-like syndrome in patients taking hydralazine, procainamide, and sulfadiazine. Over the years, multiple other agents have been linked to immune-mediated glomerular disease, often with associated autoantibody formation. Certain clinical and laboratory features may distinguish these entities from their idiopathic counterparts, and making this distinction is important in the diagnosis and management of these patients. Here, drug-induced, ANCA-associated vasculitis, drug-induced lupus, and drug-associated membranous nephropathy are reviewed.
Keywords:
ANCA; GN; SLE; drug nephrotoxicity; membranous nephropathy.
Copyright © 2015 by the American Society of Nephrology.
MeSH terms
-
Animals
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / chemically induced*
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / therapy
-
Autoantibodies / immunology
-
Autoimmunity / drug effects
-
Drug-Related Side Effects and Adverse Reactions / diagnosis
-
Drug-Related Side Effects and Adverse Reactions / etiology*
-
Drug-Related Side Effects and Adverse Reactions / immunology
-
Drug-Related Side Effects and Adverse Reactions / therapy
-
Glomerulonephritis / chemically induced*
-
Glomerulonephritis / diagnosis
-
Glomerulonephritis / immunology
-
Glomerulonephritis / therapy
-
Humans
-
Kidney Glomerulus / drug effects*
-
Kidney Glomerulus / immunology
-
Kidney Glomerulus / pathology
-
Lupus Nephritis / chemically induced
-
Lupus Nephritis / immunology
-
Prognosis
-
Risk Assessment
-
Risk Factors